Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2017-05-24 Tx date 2017-05-17 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+900,000 vol |
8,048,325 | |
Filed 2017-03-13 Tx date 2017-03-10 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,000,000 vol |
7,148,325 | |
Filed 2016-08-23 Tx date 2016-08-23 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+325,000 vol |
5,148,325 | |
Filed 2016-06-22 Tx date 2016-06-21 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,080
+16,000 vol $0.13 each |
291,000 | |
Filed 2016-06-22 Tx date 2016-06-21 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,900
+100,000 vol $0.129 each |
275,000 | |
Filed 2016-03-08 Tx date 2016-03-04 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,000,000 vol |
4,823,325 | |
Filed 2015-09-08 Tx date 2015-09-08 |
$TRL
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,860
+4,000 vol $0.465 each |
172,000 | |
Filed 2015-09-08 Tx date 2015-09-08 |
$TRL
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,335
+3,000 vol $0.445 each |
175,000 | |
Filed 2015-09-04 Tx date 2015-09-03 |
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.) |
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,990
+17,000 vol $0.47 each |
168,000 | |
Filed 2015-08-27 Tx date 2015-08-27 |
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.) |
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,700
+6,000 vol $0.45 each |
151,000 | |
Filed 2015-08-27 Tx date 2015-08-27 |
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.) |
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,185
+7,000 vol $0.455 each |
145,000 | |
Filed 2015-08-21 Tx date 2015-08-20 |
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.) |
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$574.50
+1,500 vol $0.383 each |
138,000 | |
Filed 2015-08-20 Tx date 2015-08-19 |
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.) |
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,172
+5,500 vol $0.395 each |
130,500 | |
Filed 2015-08-20 Tx date 2015-08-19 |
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.) |
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,364
+6,000 vol $0.394 each |
136,500 | |
Filed 2015-08-07 Tx date 2015-08-07 |
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.) |
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,250
+45,000 vol $0.45 each |
125,000 |